Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial

Transplant Proc. 1995 Feb;27(1):1195-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use*
  • Aspergillosis / epidemiology
  • Candidiasis / epidemiology
  • Child
  • Child, Preschool
  • Drug Carriers
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Liposomes
  • Liver Transplantation*
  • Male
  • Middle Aged
  • Mycoses / epidemiology
  • Mycoses / prevention & control*
  • Placebos
  • Postoperative Complications / epidemiology
  • Postoperative Complications / prevention & control
  • Probability
  • Risk Factors
  • Time Factors
  • Tissue Donors

Substances

  • Drug Carriers
  • Liposomes
  • Placebos
  • liposomal amphotericin B
  • Amphotericin B